Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody GlobeNewswire January 07, 2026 First patient dosed and study open in leading oncology centers in US and Australia Phase I/IIA adaptive study aims to assess and optimize the dose of OTP-01 and provide safety, tolerability, and […]

RedTeam Announces Offline Mode for RedTeam Go Mobile App Stay productive anywhere, even without connectivity GlobeNewswire January 07, 2026 Orlando, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) — RedTeam, a leading provider of construction management software, today announced the launch of Offline Mode for the RedTeam Go mobile app, a feature designed to keep critical project

NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Skye Bioscience, Inc. (NASDAQ:SKYE) securities. If you suffered a loss on your Skye Bioscience, Inc. investment and would like to explore

(TSX-V:POC),(NASDAQ:EU),(TSX-V:EU), NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SANTA FE, N.M., Jan. 07, 2026 (GLOBE NEWSWIRE) — Verdera Energy Corp. (the “Company” or “Verdera“) and POCML 7 Inc. (TSXV:POC.P) (“POCML7“), are pleased to provide an update in connection with the proposed transaction that will constitute a Qualifying

Verdera Energy Announces $20 Million Qualifying Transaction Financing GlobeNewswire January 07, 2026 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SANTA FE, N.M., Jan. 07, 2026 (GLOBE NEWSWIRE) — Verdera Energy Corp. (the “Company” or “Verdera“) and POCML 7 Inc. (TSXV:POC.P) (“POCML7“), are pleased to provide an update

NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Coupang, Inc. (NYSE:CPNG) securities. If you suffered a loss on your Coupang, Inc. investment and would like to explore a potential

Bolton, Massachusetts, Jan. 07, 2026 (GLOBE NEWSWIRE) — As hyperspectral applications increasingly move from research into real-world and production environments, Headwall today announced the appointment of Markus Schlagbauer as Chief Product Officer and Elizabeth Peck as Chief Marketing Officer. “Headwall remains at the forefront of advanced hyperspectral sensing technologies, and these appointments reinforce our focus

Mount Laurel, NJ, Jan. 07, 2026 (GLOBE NEWSWIRE) — Pinnacle Treatment Centers, a leading provider of affordable, accessible addiction treatment services, has announced the appointment of Brian Lantier as its new Chief Executive Officer. Lantier succeeds Joe Pritchard, who served as CEO from 2006-2023, and interim CEO in 2025, as Pinnacle continues to advance its

Headwall Appoints Chief Product Officer and Chief Marketing Officer As Hyperspectral Applications Scale, Headwall Reinforces Focus On Real-World Customer Value GlobeNewswire January 07, 2026 Bolton, Massachusetts, Jan. 07, 2026 (GLOBE NEWSWIRE) — As hyperspectral applications increasingly move from research into real-world and production environments, Headwall today announced the appointment of Markus Schlagbauer as Chief Product

Pinnacle Treatment Centers Appoints Brian Lantier as Chief Executive Officer GlobeNewswire January 07, 2026 Mount Laurel, NJ, Jan. 07, 2026 (GLOBE NEWSWIRE) — Pinnacle Treatment Centers, a leading provider of affordable, accessible addiction treatment services, has announced the appointment of Brian Lantier as its new Chief Executive Officer. Lantier succeeds Joe Pritchard, who served as